LUMINOS-101: Phase 2 study of PVSRIPO with pembrolizumab in recurrent glioblastoma.

Authors

null

Andrew E. Sloan

University Hospitals Cleveland Medical Center & Seidman Cancer Center, Cleveland, OH

Andrew E. Sloan , Robin Arthur Buerki , Christopher Murphy , Andrea True Kelly , Prakash Ambady , Michael Brown , Nicholas A. Butowski , Robert Cavaliere , William T. Curry , Annick Desjardins , Lisa Franklin , Henry S. Friedman , Matthias Gromeier , LeAnn Jackson , Lori Mixson , Shirley S. Ong , Dina Randazzo , Patrick Y. Wen , Garrett Nichols

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Brain Metastases

Clinical Trial Registration Number

NCT04479241

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS2065)

DOI

10.1200/JCO.2021.39.15_suppl.TPS2065

Abstract #

TPS2065

Poster Bd #

Online Only

Abstract Disclosures